MODIFIED FORMS OF LOW-DENSITY-LIPOPROTEIN AND ATHEROSCLEROSIS

[1] MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN STIMULATES MONOCYTE ENDOTHELIAL INTERACTIONS [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) : 1260 - 1266

[2] THE ANTIOXIDANT BUTYLATED HYDROXYTOLUENE PROTECTS AGAINST ATHEROSCLEROSIS [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01): : 15 - 22

[3] A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J]. SCIENCE, 1986, 232 (4746) : 34 - 47

[4] CAMEJO G, 1991, J LIPID RES, V32, P1983

[5] ANTIATHEROGENIC EFFECT OF PROBUCOL UNRELATED TO ITS HYPOCHOLESTEROLEMIC EFFECT - EVIDENCE THAT ANTIOXIDANTS INVIVO CAN SELECTIVELY INHIBIT LOW-DENSITY-LIPOPROTEIN DEGRADATION IN MACROPHAGE-RICH FATTY STREAKS AND SLOW THE PROGRESSION OF ATHEROSCLEROSIS IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) : 7725 - 7729

[6] MONOCYTES AND NEUTROPHILS OXIDIZE LOW-DENSITY LIPOPROTEIN MAKING IT CYTO-TOXIC [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1985, 38 (02) : 341 - 350

[7] MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN INDUCES MONOCYTE CHEMOTACTIC PROTEIN-1 IN HUMAN ENDOTHELIAL-CELLS AND SMOOTH-MUSCLE CELLS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) : 5134 - 5138

[8] PROBUCOL ATTENUATES THE DEVELOPMENT OF AORTIC ATHEROSCLEROSIS IN CHOLESTEROL-FED RABBITS [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (02) : 612 - 618

[9] ACTIVATION OF 15-LIPOXYGENASE BY LOW-DENSITY-LIPOPROTEIN IN VASCULAR ENDOTHELIAL-CELLS - RELATIONSHIP TO THE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1992, 45 (01): : 49 - 57

[10] MALONDIALDEHYDE ALTERATION OF LOW-DENSITY LIPOPROTEINS LEADS TO CHOLESTERYL ESTER ACCUMULATION IN HUMAN MONOCYTE-MACROPHAGES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (04): : 2214 - 2218

[1] MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN STIMULATES MONOCYTE ENDOTHELIAL INTERACTIONS [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) : 1260 - 1266

[2] THE ANTIOXIDANT BUTYLATED HYDROXYTOLUENE PROTECTS AGAINST ATHEROSCLEROSIS [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01): : 15 - 22

[3] A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J]. SCIENCE, 1986, 232 (4746) : 34 - 47

[4] CAMEJO G, 1991, J LIPID RES, V32, P1983

[5] ANTIATHEROGENIC EFFECT OF PROBUCOL UNRELATED TO ITS HYPOCHOLESTEROLEMIC EFFECT - EVIDENCE THAT ANTIOXIDANTS INVIVO CAN SELECTIVELY INHIBIT LOW-DENSITY-LIPOPROTEIN DEGRADATION IN MACROPHAGE-RICH FATTY STREAKS AND SLOW THE PROGRESSION OF ATHEROSCLEROSIS IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) : 7725 - 7729

[6] MONOCYTES AND NEUTROPHILS OXIDIZE LOW-DENSITY LIPOPROTEIN MAKING IT CYTO-TOXIC [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1985, 38 (02) : 341 - 350

[7] MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN INDUCES MONOCYTE CHEMOTACTIC PROTEIN-1 IN HUMAN ENDOTHELIAL-CELLS AND SMOOTH-MUSCLE CELLS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) : 5134 - 5138

[8] PROBUCOL ATTENUATES THE DEVELOPMENT OF AORTIC ATHEROSCLEROSIS IN CHOLESTEROL-FED RABBITS [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (02) : 612 - 618

[9] ACTIVATION OF 15-LIPOXYGENASE BY LOW-DENSITY-LIPOPROTEIN IN VASCULAR ENDOTHELIAL-CELLS - RELATIONSHIP TO THE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1992, 45 (01): : 49 - 57

[10] MALONDIALDEHYDE ALTERATION OF LOW-DENSITY LIPOPROTEINS LEADS TO CHOLESTERYL ESTER ACCUMULATION IN HUMAN MONOCYTE-MACROPHAGES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (04): : 2214 - 2218